ADVOCATE. CONNECT. INNOVATE.

Bulletin, Member News

CLSA Hosts Lilly Partnering Day

On July 21 and 22, CLSA hosted a successful Partnering Day with Eli Lilly and over thirty CLSA member companies in California. CLSA’s Partnering Day program provides global pharmaceutical and medical device technology buyers and high quality emerging life science companies the opportunity to participate in targeted one-on-one meetings, providing access to novel technologies for co-development.

The event started on July 21st with a Networking Cocktail Reception that was open to the C-level suite of California-based bioscience companies. Following the reception, we held a private dinner with Lilly staff and various Venture Capitalists from the Bay Area.  Representatives from Frazier Management, Sofinnova Ventures, Vivo Capital, Arch, Versant Ventures, Canaan, Mission Bay Capital, Pappas Ventures, and Life Science Angels were all present.

Johnston Erwin, Global Brand Development Leader of Eli Lilly, kicks off Lilly Partnering Day
Johnston Erwin, Global Brand Development Leader of Eli Lilly, kicks off Lilly Partnering Day

On July 22nd, Johnston Erwin, Global Brand Development Leader of Eli Lilly and Ed Torres, Co-founder & Managing Director of Lilly Ventures gave a morning plenary describing Lilly’s partnering strategy. Following the plenary address, we held a panel discussion with 5 key members of Eli Lilly’s Research & Development Team moderated by CLSA’s CEO Sara Radcliffe.

Hanwei Li, Corporate Forum Liaison of Stanford BioX, meets with Chris Vlahos, Director of Global External R&D, Eli Lilly, and Brian Bloomquist, Senior Director, Eli Lilly, during Lilly Partnering Day.
Hanwei Li, Corporate Forum Liaison of Stanford BioX, meets with Chris Vlahos, Director of Global External R&D, Eli Lilly, and Brian Bloomquist, Senior Director, Eli Lilly, during Lilly Partnering Day.

At the conclusion of the morning events, we hosted a small roundtable luncheon with Principal Investigators from Bay Area universities in the target areas of Device, Neuroscience, and Diabetes. Representatives from Stanford, UCSF, UC Berkeley, and The Gladstone Institutes participated in this luncheon.

Brian Edmonds, Director of Global External R&D, Eli Lilly, addresses Californian life science entrepreneurs during the plenary session of Lilly Partnering Day.
Brian Edmonds, Director of Global External R&D, Eli Lilly, addresses Californian life science entrepreneurs during the plenary session of Lilly Partnering Day.

We closed the event with a series of private one-on-one meetings with pre-approved California-based companies and Lilly team members that revolved around 7 different therapeutic areas; Oncology, Neuroscience, Immunology, Diabetes, Cardiovascular, Discovery Research, and Drug Delivery/Devices.

If you are interested in sponsoring a CLSA Partnering Day, please contact our membership team at membership@califesciences.org. If you are an emerging company interested in a one on one Partnering Day meeting, view upcoming Partnering Days here.